Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 48 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Glucagon-like peptides 1 and 2 in health and disease: A reviewMarathe, C.; Rayner, C.; Jones, K.; Horowitz, M.
2001Gastroparesis: prevalence clinical significance and treatmentHorowitz, M.; Su, Y.; Rayner, C.; Jones, K.
2007Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjectsKaramanlis, A.; Chaikomin, R.; Doran, S.; Bellon, M.; Bartholomeusz, D.; Wishart, J.; Jones, K.; Horowitz, M.; Rayner, C.
2007Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy menPilichiewicz, A.; Chaikomin, R.; Brennan, I.; Wishart, J.; Rayner, C.; Jones, K.; Smout, A.; Horowitz, M.; Feinle-Bisset, C.
2010Dietary effects on incretin hormone secretionWu, T.; Rayner, C.; Jones, K.; Horowitz, M.; Gerald Litwack,
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2018Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and managementDu, Y.; Rayner, C.; Jones, K.; Talley, N.; Horowitz, M.
2015Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance testMarathe, C.; Horowitz, M.; Trahair, L.; Wishart, J.; Bound, M.; Lange, K.; Rayner, C.; Jones, K.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.